BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2402224)

  • 1. Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol.
    Bornheim LM; Correia MA
    Mol Pharmacol; 1990 Sep; 38(3):319-26. PubMed ID: 2402224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol.
    Bornheim LM; Correia MA
    Mol Pharmacol; 1989 Sep; 36(3):377-83. PubMed ID: 2779523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily.
    Bornheim LM; Correia MA
    Mol Pharmacol; 1991 Aug; 40(2):228-34. PubMed ID: 1875910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cannabidiol on cytochrome P-450 isozymes.
    Bornheim LM; Correia MA
    Biochem Pharmacol; 1989 Sep; 38(17):2789-94. PubMed ID: 2550010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver.
    Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H
    Drug Metab Dispos; 1988; 16(6):880-9. PubMed ID: 2907469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem.
    Pichard L; Gillet G; Fabre I; Dalet-Beluche I; Bonfils C; Thenot JP; Maurel P
    Drug Metab Dispos; 1990; 18(5):711-9. PubMed ID: 1981725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
    Stevens JC; Halpert J
    Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF; Waxman DJ
    Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver.
    Riddick DS; Park SS; Gelboin HV; Marks GS
    Mol Pharmacol; 1989 May; 35(5):626-34. PubMed ID: 2725472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat.
    List A; Nazar B; Nyquist S; Harclerode J
    Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene.
    Cresteil T; Beaune P; Celier C; Leroux JP; Guengerich FP
    J Pharmacol Exp Ther; 1986 Jan; 236(1):269-76. PubMed ID: 3941398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
    Ohmori S; Shirakawa C; Motohashi K; Yoshida H; Abe H; Nakamura T; Horie T; Kitagawa H; Asaoka K; Rikihisa T
    Mol Pharmacol; 1993 Feb; 43(2):183-90. PubMed ID: 8429823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450.
    Ciaccio PJ; Duignan DB; Halpert JR
    Drug Metab Dispos; 1987; 15(6):852-6. PubMed ID: 2893713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
    Cook CS; Hauswald C; Oppermann JA; Schoenhard GL
    J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a PCN-P450 enzyme in chickens and comparison of its development with that of other phenobarbital-inducible forms.
    Lorr NA; Bloom SE; Park SS; Gelboin HV; Miller H; Friedman FK
    Mol Pharmacol; 1989 May; 35(5):610-6. PubMed ID: 2725470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo.
    Halpert J; Balfour C; Miller NE; Morgan ET; Dunbar D; Kaminsky LS
    Mol Pharmacol; 1985 Sep; 28(3):290-6. PubMed ID: 4033629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver.
    Craig PI; Mehta I; Murray M; McDonald D; Aström A; van der Meide PH; Farrell GC
    Mol Pharmacol; 1990 Sep; 38(3):313-8. PubMed ID: 1698250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450-dependent monooxygenase activities and their inducibility by classic P450 inducers in the liver, kidney, and nasal mucosa of male adult ring-necked pheasants.
    Giorgi M; Marini S; Longo V; Mazzaccaro A; Amato G; Gervasi PG
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):237-45. PubMed ID: 10986015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation.
    Martini R; Murray M
    Arch Biochem Biophys; 1993 May; 303(1):57-66. PubMed ID: 8489266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.